TSX:CPH - Post Discussion
Post by
pabaloo on Jan 11, 2021 9:44am
No Generic Launch!
Absorica and Absorica LD prescriptions – With looming threat of generic substitution, Sun has
been able to convert 27% of the Absorica prescriptions to Absorica LD.
This is as of December 10, 2021. The pie will get very small for any generic soon as all scripts will be switched to the LD version which is safer and has a much higher absorption rate. I can't see any reason for a generic launch at this point Sun did a great job of keeping there own market. Now they need to start marketing this product to increase there share. They can easily hold double what they hold now.
Be the first to comment on this post